Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cost-effectiveness of follitropin delta vs follitropin alpha in controlled ovarian stimulation
jRCT1031230698Recruiting
- Sponsor
- Nothing
- Start
- Mar 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of follitropin delta and follitropin alfa in female infertility (2 arms), sponsored by Nothing. Primary endpoint: Incremental cost-effectiveness ratio (ICER) based on cumulative pregnancy rate. Started Mar 2024; status: recruiting.
02
Drugs
follitropin deltafollitropin alfa
03
Conditions
female infertility
Beyond the preview
Go deeper on jRCT1031230698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1031230698.